Operator fluency on fresh ground: management answers probing questions about a new driver with unhesitating operational
The model's full reasoning — Q3 2023 call → NOWe need to determine if the transcript shows the dynamic described. The question asks about a "recently emerged positive element of the business" whose meaningful contribution began only within roughly the last few quarters. Analysts probe it, and management responds with unhesitating, granular operational command, answering follow-ups with specific present-tense working detail, while conveying that the element's contribution is still early. We need to identify what element is being probed. The transcript includes Q&A. Analysts ask about various things: FDA appeal, Brazil/Canada approvals, China/Japan, CIRSE workshop, comparator group, revenue trends, etc. The key is to find an element that is "recently emerged" and "young" per management's framing. Possibly the Brazil approval? Or the independent studies? Or the CIRSE hand-on? Or the new distributor in Portugal? Or the India procedure? Or the new VP of sales? Let's examine the Q&A. The first question from Anthony Vendetti asks about FDA approval status and then about Brazil and China. Management answers about Brazil: "after we got started our commercial activities, the orders were skipped. Out of the participating two conferences, we had a group of top KOLs who came to Israel a few months ago for training. So we could see it start also penetration and working with the top KOL to penetrate the Brazilian market." That's some detail but not very granular. Then about China: "I just came back from China and Japan, a business trip. And in China as well, we are exploring, participating, achieving some coding and reimbursement and starting our penetration in the Chinese market." That's more general. Then Ben Haynor asks about comparator group, and then about CIRSE hand-on. Tlalit answers about CIRSE: "It was overbooked. There is a room for a certain amount of people, and they had to pre-register, and the room was full, and there was a waiting list. And in all, whenever we do a hand-on, we see that we have a full house, and there is a lot of engagement, a lot of interest, and then after the workshop we have people coming to IceCure Booths to learn more. And one more thing to elaborate on that is the clear benefit of IceCure versus other companies that are working in cryoablation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| MCD | McDonald's Corporation | Q2 2024 | 2024-07-29 | D |
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| CTRA | Coterra Energy Inc. | Q1 2024 | 2024-05-03 | A |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| EGP | EastGroup Properties, Inc. | Q4 2023 | 2024-02-08 | B |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| WGO | Winnebago Industries, Inc. | Q1 2023 | 2022-12-16 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| ALHC | Alignment Healthcare, Inc. | Q3 2021 | 2021-11-06 | B+ |
| FFWM | First Foundation Inc. | Q3 2021 | 2021-10-26 | B |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| FI | Fiserv, Inc. | Q4 2017 | 2018-02-27 | C |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| NDSN | Nordson Corporation | Q3 2016 | 2016-08-23 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| ENLC | EnLink Midstream, LLC | Q4 2015 | 2016-02-17 | C+ |
IRT · Q2 2018 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it. YES The transcript shows management providing unhesitating, granular operational detail on the value-add program—a recently emerged positive element whose meaningful contribution began within the last few quarters—as probed by analysts like John Massocca and Craig Kucera. They discuss specifics such as NOI growth from phase 1 rehabs in 4Q 18 (14-15% range), phase 2 as a slight drag, $4.
LTRX · Q3 2024 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.
NICE · Q4 2023 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.